139264-24-7 (佐米曲坦R-异构体,(R)-4-3-2-(Dimethylamino)ethyl-1H-indol-5-ylmethyl-2-oxazolidinone(Zolmitriptan R-Isomer))

佐米曲坦R-异构体;佐米曲坦R异构体;R-佐米曲坦;R-佐米曲坦异构体 USP标准品;佐米R-异构体;(4R)-4-[[3-[2-(二甲基氨基)乙基]-1H-吲哚-5-基]甲基]-2-恶唑烷酮;

(R)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one;(R)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone (Zolmitriptan R-Isomer);(4R)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one;(R)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone (Zolmitriptan R-Isomer);(R)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone (Zolmitriptan R-Isomer) ;Flezol;Zolmitriptan RapidFilm;Zomig Rapimelt;(R)-4-({3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one;Zolmitriptan R-isomer;(4R)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one;ZOLMITRIPTAN R-ISOMER [USP-RS];(4R)-4-((3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-5-YL)METHYL)-1,3-OXAZOLIDIN-2-ONE;ZOLMITRIPTAN R-ISOMER [USP IMPURITY];(4R)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one;Zolmitriptan, (R)-;2-Oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-, (4R)-;AKOS015895148;(R)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone(Zolmitriptan R-Isomer);(R)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl(methyl)oxazolidin-2-one;2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4R)-;NS00007368;UNII-F3YOE57701;ZOLMITRIPTAN IMPURITY A [EP IMPURITY];Q27277594;(4R)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone;;F3YOE57701;SCHEMBL40595;(R)-Zolmitriptan;139264-24-7;Zolmitriptan R-isomer RS [USP];

MFCD12546349

ULSDMUVEXKOYBU-CYBMUJFWSA-N

1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m1/s1

O1C(N[C@@H](C1)CC1C=CC2=C(C=1)C(=CN2)CCN(C)C)=O